Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Surgery × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 126 Carcinoma, Non-Small-Cell Lung 91 Colorectal Neoplasms 82 Carcinoma, Hepatocellular 66 Stomach Neoplasms 60 Rectal Neoplasms 48 Neoplasms 47 Lung Neoplasms 43 Nasopharyngeal Carcinoma 38 Leukemia, Myeloid, Acute 37 Lymphoma, Large B-Cell, Diffuse 36 Colonic Neoplasms 36 Prostatic Neoplasms 33 Neoplasm Metastasis 33 Uterine Cervical Neoplasms 32 Ovarian Neoplasms 29 Multiple Myeloma 29 Lymphoma, Follicular 29 Esophageal Neoplasms 29 Lymphoma 27 Pancreatic Neoplasms 26 Leukemia 26 Recurrence 22 Brain Neoplasms 20 Urinary Bladder Neoplasms 18 Lymphoma, Non-Hodgkin 18 Head and Neck Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Mantle-Cell 16 Leukemia, Lymphocytic, Chronic, B-Cell 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05035446 2021-10-11

Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer

Fujian Cancer Hospital

Phase 3 Unknown

Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡